Home| Journals | About Us|Contact Us|www.statperson.com

 
Untitled Document

[Abstract] [PDF] [HTML] [Linked References]

To study the clinico-labrotary correlation of stroke due to intracranial extracranial and combined vascular lesions

Anjali Deshmukh1*, Sanjiv Zangde2
1
Consutant Physician, Suryakant Consultant, Nanded, Maharashtra, INDIA.

1Consutant Physician, Vighnharta Critical Care and Multispecialty Hospital, Borban, Nanded, Maharashtra, INDIA.

Email: dr.dranju@rediffmail.com, drsanjivzangde98@gmail.com

Research Article

Abstract               Introduction: Although dyslipedimia is a well established risk factor for coronary artery disease, its relationship to ischemic cerebrovascular disease has remained unclear, perhaps because of the heterogeneous nature of stroke. Aims and Objectives: To study the clinico-laboratory correlation of stroke due to intracranial, extracranial and combined vascular lesions. Material and Method: in the present study 104 cases of ischemic stroke were included in the study. All these patients were studied clinically and radiologically to study the nature of lesion (intracranial or extracranial vascular lesion). Neuroimaging- MRI-Brain or CT-Brain was done in each patient to see site of infarct. Routine laboratory evaluation- blood sugar, renal function tests, haemogram, lipid profile and serum vitamin B12 and homocysteine levels are calculated in all patients. Results: 49.04% of patients included in our study were having vitamin B12 deficiency. Raised serum homocysteine levels were seen in 61.54% patients. Hypertension was found in 76.92% of total patients whereas 41.35% of patients were having diabetes mellitus. 30.77% of patients with ischaemic stroke were having hypercholesterolaemia. It was observed that 33.65% patients of ischaemic stroke were having raised serum triglyceride levels and 52.88% patients were having raised LDL levels. Patients having low HDL cholesterol levels were 67.30%. Conclusion: Thus we conclude that raised homocysteine levels, hypercholesterolaemia, hypertriglyceridaemia and raised LDL levels are found to be important risk factors for ischaemic strokes due to extracranial vascular lesion. HDL appears to have protective influence on extracranial vascular lesion.

Keywords: intracranial extracranial, vascular lesions.

 

INTRODUCTION

Although dyslipedimia is a well established risk factor for coronary artery disease, its relationship to ischemic cerebrovascular disease has remained unclear, perhaps because of the heterogeneous nature of stroke. Among all the neurologic diseases of adult life, the stroke clearly rank first in frequency and importance accounting upto 20% of all central nervous system disorders, in the urban sectors of India. Stroke is defined as an abrupt neurologic deficit that is attributable to focal vascular cause. Risk factors for stroke include hypertension, carotid stenosis, atrial myxomas, smoking, hyperlipidemia, diabetes, myocardial infarction and atrial fibrillation. Nikolai Anichkov first proposed a link between cholesterol and atherosclerosis in 1912. Decades later observational studies have incontrovertibly established hyperlipidemia as an independent risk factor for coronary artery disease. The link between hyperlipidemia and stroke was more difficult to establish. The difficulty arose in part because of the heterogeneous nature of stroke. To investigate a possible etiologic relationship between hyperlipidemia and stroke, it became essential to distinguish ischemic from hemorrhagic stroke. It now appears likely that hyperlipidemia is an independent risk factor for ischemic stroke. Atherosclerosis of arteries, extracranial and intracranial is the most prominent cause of stroke and hyperlipidemia is a major risk factor for atherosclerosis. Most of the evidence specifically implicates hypercholesterolemia and to a lesser extent hypertriglyceridemia in the causation of atherosclerosis. The mechanisms by which hyperlipidemia contributes to atherogenesis are many.1 The atherosclerotic plaques in the arterial walls contain large amounts of cholesterol. The higher the level of LDL cholesterol, the greater is the risk of atherosclerotic heart disease; conversely, the higher the HDL cholesterol, the lower is the risk of CHD. The effect of HDL cholesterol is greater in women, whereas the effects of total and LDL cholesterol are comparatively smaller and of these relationships diminish with age.2 The size of the LDL molecule also influences atherogenesis; at the same LDL concentrations, individuals with large numbers of smaller particles appear to be at higher risk for CHD. 3,4

The relationship of VLDL cholesterol to atherogenesis is less clear. The number, size, or subtype and the total amount in serum of VLDL particles may be important. In addition, HDL and VLDL levels are inversely related. Patients with a high VLDL level are at increased risk for CHD as they are likely to have a low HDL level.5,6

 

AIMS AND OBJECTIVES

To study the clinico-laboratory correlation of stroke due to intracranial, extracranial and combined vascular lesions.

 

MATERIAL AND METHOD

The present cross sectional study was conducted at Ruby Hall Clinic, Pune to study the clico laboratory profile of ischemic stroke patients. Following inclusion and exclusion criteria was used to select the study subjects.

Inclusion criteria

All the patients admitted to Ruby Hall Clinic, Pune with sudden onset neurological deficit and diagnosed to have TIA, ischaemic stroke or leukoaraiosis are included in this study.

Exclusion criteria

All cases suggestive of cardio-embolic stroke and haemorrhagic stroke are excluded from this study. By using the above mentioned inclusion and exclusion criteria total 104 patients of were enrolled in the study in one year. Detailed case history was taken for each patient regarding history of current illness, past history of similar events, treatments, transient ishaemic attacks and history suggestive of risk factors like hypertension, Diabetes mellitus, ischaemic heart disease, old stroke, smoking history was noted. General examination and systemic examination was performed on each patient. Detailed neurological examination was done to localise site of lesion. Cardiovascular examination was done to rule out any cardiac disease leading to embolisation and stroke. Routine laboratory evaluation- blood sugar, renal function tests, haemogram, lipid profile and serum vitamin B12 and homocysteine levels are studied. All the patients were studied clinically and radiologically to study the nature of lesion (intracranial or extracranial vascular lesion). Neuroimaging- MRI-Brain or CT-Brain was done in each patient to see site of infarct. Patients with haemorrhagic stroke and venous sinus thrombosis are excluded. Subsequently CT-angiogram, MR-angiogam or Digital substraction Angiography was done to study site of occlusion in vessels. Lesion which is not causing any symptoms or signs is considered as normal. Accordingly clinical and radiological correlation of strokes due to intracranial and extracranial vascular lesion and associated risk factors like hypertension, Diabetes mellitus, vitamin B12 and homocysteine levels, dyslipidaemia, hyperhomocysteinaemia were studied.


 

RESULTS

Table 1: Clinico-laboratory risk factors associated with ischaemic stroke

Risk factors

Intracranial vascular lesions

Extracranial vascular lesions

Combined vascular lesions

Normal angiogram

Total

vitamin B12

B12 deficiency

15 (50%)

18 (54.55%)

4 (50%)

14 (42.42%)

51 (49.04%)

Normal B12

15 (50%)

15 (45.45%)

4 (50%)

19 (57.58%)

53 (50.96%)

homocysteine levels

Hyperhomocysteinaemia

18 (60%)

24 (72.73%)

5 (62.50%)

17 (51.52%)

64 (61.54%)

Normal homocysteine

12 (40%)

9 (27.27%)

3 (37.50%)

16 (48.48%)

40 (38.46%)

Hypertension

HTN

25 (83.33%)

25 (75.76%)

7 (87.50%)

23 (69.70%)

80 (76.92%)

Non-HTN

5 (16.67%)

8 (24.24%)

1 (12.50%)

10 (30.30%)

24 (23.08%)

Diabetes

DM

15 (50.00%)

15 (45.45%)

1 (12.50%)

12 (36.36%)

43 (41.35%)

Non-DM

15 (50.00%)

18 (54.55%)

7 (87.50%)

21 (63.64%)

61 (58.65%)

 


Vitamin B12 deficiency appears to be an important risk factor for stroke. 49.04% of patients included in our study were having vitamin B12 deficiency. 50% of stroke patients with intracranial vascular lesion were having vit.B12 deficiency, 54.55% with extracranial vascular lesion were having vit.B12 deficiency, 50% of patients with combined lesion were having vit.B12 deficiency and 42.42% of patients with normal angiogram were having vit.B12 deficiency. 61.54% of total patients were having raised serum homocysteine levels, out of which 60% patients were with intracranial vascular lesion, 72.73% patients with extracranial vascular lesion, 62.5% patients with combined vascular lesion and 51.52% patients were with normal angiographic study. Hypertension appears to be an important risk factor for stroke. Hypertension was found in 76.92% (80 out of 104) of total patients. 83.33% of stroke patients in our study with intracranial vascular lesion were having hypertension, 75.76% patients with extracranial vascular lesion were having hypertension, 87.5% patients with combined intracranial and extracranial vascular lesions were having hypertension and 69.7% of stroke patients with normal angiogram were having hypertension. HTN has positive correlation with intracranial vascular lesions as compared to extracranial vascular lesions, but difference is not stastistically significant (p=0.53). 41.35% of patients in our study were having diabetes mellitus. 50% of patients with intracranial vascular lesion were diabetic, 45.45% patients with extracranial vascular lesion were diabetic, 12.5% patients with combined lesion were diabetic and 36.36% of stroke patients with normal angiogram were diabetic. 33.65% of stroke patients in our study were having past history of ischaemic heart disease. 14.42% of patients in our study were having history of prior stroke.


 

Table 2: Association of lipid profile with ischaemic stroke

Lipid profile

Intracranial vascular lesions

Extracranial vascular lesions

Combined vascular lesions

Normal angiogram

Total

Total cholesterol

High

9 (30.00%)

12 (36.36%)

2 (25.00%)

9 (27.27%)

32 (30.77%)

Normal

21 (70.00%)

21 (63.64%)

6 (75.00%)

24 (72.73%)

72 (69.23%)

Triglyceride

Hypertriglyceridaemia

7 (23.33%)

16 (48.48%)

2 (25.00%)

10 (30.30%)

35 (33.65%)

Normal TG

23 (76.67%)

17 (51.52%)

6 (75.00%)

23 (69.70%)

69 (66.35%)

LDL levels

High LDL

16 (53.33%)

21 (63.64%)

4 (50.00%)

14 (42.42%)

55 (52.88%)

Normal LDL

14 (46.67%)

12 (36.36%)

4 (50.00%)

19 (57.58%)

49 (47.12%)

HDL

Low HDL

19 (63.33%)

24 (72.73%)

5 (62.50%)

22 (66.67%)

70 (67.31%)

Normal HDL

11 (36.67%)

9 (27.27%)

3 (37.50%)

11 (33.33%)

34 (32.69%)

 

Figure 1: Association of lipid profile with ischaemic stroke

 


In our study, 30.77% of patients with ischaemic stroke were having hypercholesterolaemia. 30% patients with intracranial vascular lesion, 36.36% patients with extracranial vascular lesion, 25% patients with combined lesion, 27.27% stroke patients with normal angiogram were having high serum cholesterol levels. It was observed that 33.65% patients of ischaemic stroke were having raised serum triglyceride levels. 23.33% patients with intracranial vascular lesion, 48.48% patients with extracranial vascular lesion, 25% patients with combined lesion and 30.30% patients with normal angiographic studies were having raised serum triglyceride levels. 52.88% patients were having raised LDL levels. 53.33% patients with intracranial vascular lesion, 63.64% patients with extracranial vascular lesion and 50% patients with combined lesion whereas 42.42% patients with normal angiographic findings were having high LDL levels.

Patients having low HDL cholesterol levels were 67.30%. It was seen that 63.33% patients were with intracranial vascular lesion, 72.72% patients with extracranial vascular lesion, 62.5% patients with combined vascular lesion and 66.66% patients with normal angiographic findings were having low HDL cholesterol levels.

 

DISCUSSION

The Present study was conducted at Ruby Hall Clinic, Pune on patients admitted with sudden onset neurological deficit and diagnosed to have ischaemic stroke to study the clinico-labrotary correlation. It was observed that 49.04% of our patients were having vitamin B12 deficiency. In Indian patients vitamin B12 deficiency is an important risk factor for ischaemic stroke, it was also observed by wadia et al7. Robertson et al8 also found association of vitamin B12 deficiency with ischaemic strokes. In our study, 54.55% of ischaemic stroke patients with extracranial vascular lesion were having vitamin B12 deficiency. Suwanwela et al9 also showed association of vitamin B12 deficiency with extracranial strokes.

When association of hyperhomocysteinaemia with ischaemic stroke was studied it was observed that 61.54% of stroke patients were having raised plasma homocysteine levels. Similar observations were also reported by Yoo JH et al10. 72.73% patients with extracranial vascular lesions were having raised plasma homocysteine levels. Suwanwela et al9 has also showed raised plasma homocysteine levels as an important risk factor for extracranial vascular lesion. Hypertension was found in 76.92% of total stroke patients. According Yip PK et al11 hypertension was present in 69% cases of stroke. Shrivastava et al12 also observed 67% of stroke patients were having hypertension. In our study, 83.33% patients with intracranial vascular lesion were having hypertension. Berne et al13 also states that hypertension is an independent risk factor for intracranial stenosis. It was observed that 41.35% patients were having diabetes mellitus. Ralph et al46 also observed diabetes as an independent risk factor for ischaemic stroke. It was also observed that 50% patients with intracranial strokes have diabetes. Similar observeations were also reported by Rincon F14. Hypercholesterolaemia was observed in 30.77% of patients of ischaemic stroke. National Cholesterol Education Programme also suggested hypercholesterolaemia as an important risk factor for ischaemic stroke15. Navi BB16 also states association of hypercholestrolaemia and ischaemic stroke. 36.36% patients with ischaemic strokes due to extracranial vascular lesion were having raised serum total cholesterol levels. Heiss G et al17 also found positive relationship between raised total cholesterol levels and stroke extracranial vascular lesion. It was seen that serum triglyceride levels were increased in 33.65% of patients with ischaemic stroke. Bonaventure et al18 also mentioned increased risk of ischaemic stroke with increased serum triglyceride levels. 48.48% patients with extracranial vascular lesion were having raised serum triglyceride levels. Christopher et al19 also found raised triglycerides as a risk factor for ischaemic stroke. When association of raised LDL levels with ischaemic strokewas studied it was observed that 52.88% patients were having raised levels of low density lipoprotein (LDL). Zhao Cx et al20 in therir study also observed high LDL levels as an independent risk factor for ischaemic strokes. 63.64% patients with extracranial vascular lesion in our study were having raised LDL levels. Heiss G et al15 have also mentioned about positive correlation of raised LDL levels with extracranial strokes. It was observed that 67.31% patients with ischaemic stroke were having low levels of high density lipoproteins (HDL). In a study carried out by Uddin MJ et al21, low HDL levels was found to be a risk factor for ischaemic stroke. It was also observed that 72.73% patients with extracranial vascular lesion were having low HDL levels. Heiss G et al15 also states protective influence of HDL in extracanial vascular lesions leading to stroke in their study.

 

CONCLUSION

Thus we conclude that raised homocysteine levels, hypercholesterolaemia, hypertriglyceridaemia and raised LDL levels are found to be important risk factors for ischaemic strokes due to extracranial vascular lesion. HDL appears to have protective influence on extracranial vascular lesion.

 

REFERENCES

  1. Steinberg D: Oxidative modification of LDL and atherogenesis. Circulation 95:1062, 1997.
  2. Gordon T, Kannel WB, Castelli WP, Dawber TR. Lipoproteins, cardiovascular disease, and death: the Framingham Study. Arch Intern Med. 1981; 141(9):1128-1131.
  3. Haheim LL, Holme I, Hjermann I, Leren P. Risk factors of stroke incidence and mortality: a 12-year follow-up of the Oslo Study. Stroke. 1993; 24(10):1484-1489.
  4. Lindenstrøm E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994; 309(6946):11-15.
  5. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998; 29(7):1341-1346.
  6. Bowman TS, Sesso HD, Ma J, Kurth T, Kase CS, Stampfer MJ, et al. Cholesterol and the risk of ischemic stroke. Stroke. 2003; 34(12):2930-2934.
  7. Wadia RS, Bhagat S, Edul NC, Deshmukh P, Shah M, Bandishti S, Kulkarni R. Annals of Indian Academy of Neurology 1999;2:35.
  8. Robertson J, Lemelo F, Stabler SP, Allen RH, Spence JD. Vitamin B12, homocysteine and carotid plaque in the era of fortification of enriched cereal grain products. CMAJ, Jun 2005; 172(12) 1569-73.
  9. Suwanwela NC, Chutinetr A. Risk factors for atherosclerosis of cervicocerebral arteries: intracranial versus extracranial.: Neuroepidemiology 2003;22:37– 40.
  10. Yoo JH, Chung CS, Kang SS. Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke 1998; 29:2478-83.
  11. Yip PK, Jend JS, Lee TK, Chang YK, Huang ZS et al. subtypes of ischaemic strokes: A hospital based stroke registry in Taiwan. Stroke Dec 1997; 25(12):2507-12.
  12. Srivastava A, Padma MV, Jain S, Maheshwari MC. Risk factor analysis and genetic influences of stroke: A case control study; Annal Ind Ac Neurol, vol2: suppl1:123.
  13. Berne JD, Renauld KS, Villareal DH, Mc Govern TM, Roue SA, Norwood SH et al. Sixteen slice multi-detector computed tomographic angiography improves accuracy of screening for blunt CVA. J Trauma 2006; 60:1204-9, discussion 1209-10.
  14. Rincon F. Incidence and risk factors of intracranial atherosclerotic stroke: The Northern Manhatten study. Cerebrovasc Dis. Jan 2009; 28(1) 65-71.
  15. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: Associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991; 134:250-256.
  16. Navi BB. The role of cholesterol and statins in stroke. Curr Cardiol Rep; Jan 2009; 11(1):4-11.
  17. Summary of the National Cholesterol Education Programme (NCEP) Adult treatment panel 2 report. JAMA 1993; 269:3015-3023.
  18. Bonaventure A et al. Triglycerides and risk of haemorrhgic stroke Vs Ischaemic strokes:The three-city study;Atherosclerosis May 2010;210(1): 243-8
  19. Christopher FT, Gutti RR et al. Triglyceride as a risk factor for extracranial atherosclerotic cerebrovascular disease. Angiology Jul 1983; 34:452-454.
  20. Zhao CX. Small dense low density lipoproteins and associated risk factors in patients with stroke. Cerebrovasc Dis Jan 2009; 27(1):99-104.
  21. Uddin MJ et al. Association of lipid profile with ischaemic stroke; Mymensingh Med J; Jul 2009; 18(2): 131-5.



 

 
 
 
 
 
 
     
  Copyrights statperson consultancy www

Copyrights © MedPulse Publishing Corporation www.medpulse.in  2017. All Rights Reserved.